We specialize in the diagnosis, treatment and care of people with Alzheimer’s disease, dementia, cognitive impairment or mental health concerns.
Our international clinics are global-leaders in providing volunteers with access to new treatments for Alzheimer’s disease, free of charge. We are delighted to be members of the Global Alzheimer Platform Foundation and are committed to providing excellent patient-centric care.
We provide access to ground-breaking Alzheimer’s disease treatments through clinical trials.
New medications for memory loss and Alzheimer’s disease are available in international memory studies, which are being conducted across the globe.
With more than 5.7 million people living with a diagnosis of mild cognitive impairment or dementia in the United States, we are committed to providing individuals with access to pioneering disease-modifying medications.
The drugs available in the different Alzheimer’s memory studies each work in different ways. This is called the ‘mechanism of action’. As part of the initial enrollment process, our expert team will discuss all of the memory studies available at our research center, ensuring you are fully informed and matched to the memory study most appropriate for you.
Our clinical team is very involved in the enrollment process. They are available to discuss the key requirements of the study and to educate volunteers on the different investigations and medical procedures that take place throughout the study. All of the care provided is at no cost to the volunteer. We will also reimburse reasonable travel expenses for each of your visits.
For more information, simply complete the form below.
The enrollment process is simple and is managed by our dedicated patient coordinators. Our expert team will communicate with you at each stage of the process and keep you fully-informed at all times. Simply complete the short registration form and one of our patient coordinators will be in touch to explain the memory studies in further detail.
We understand joining a memory study is a big commitment. That's why we are dedicated to ensuring you are completely comfortable with all of the requirements, commitments and details related to the study. If you would like to speak with a member of our team in person, register for one of our free presentations. Simply complete the short form below and we will be in touch to confirm your registration. Presentations typically take place at our clinic: 8316 Arlington Blvd., Suite 420, Fairfax, VA 22031. We look forward to meeting you!
A) Volunteers are not paid for taking part in this Alzheimer's research. However, the sponsor will reimburse reasonable travel expenses for you and your study partner for each visit.
A) A study partner is someone who accompanies the participant to some study visits and can answer questions about the volunteer’s symptoms. The study partner should be someone who sees the volunteer regularly (e.g., a spouse, relative or close friend) as they will need to inform us about any potential changes in the volunteer’s health or behavior. The number of visits he or she needs to attend depends on each study.
A) This depends on the research study. The screening portion of the study is generally when the visits are most frequent. This is when all initial screening is conducted to confirm whether a volunteer is eligible for a study. During the treatment stage of the study, the visits will be less frequent. Some studies require a clinic visit once a month; other studies require a visit every six weeks. If you enroll in a study, we will be able to give you all of your appointments in advance.
A) Unfortunately all of the current studies are for Alzheimer’s disease. However, we are always activating new Alzheimer's research studies, so please make sure to connect with our team using the contact form so we can keep you updated.
A) Yes. If you are eligible for one of the clinical trials, you will consent to be assigned to a treatment group. Depending on the trial, the trial medication may be in the form of a tablet taken orally once a day or an intravenous infusion once a month.
A) No. You will not know whether you are taking the active study drug or a placebo. A placebo is a similar looking tablet, but doesn't contain any active drug. You will be randomly assigned to a study groups and you and your study team will not know which group you are in. This is called a randomised, double-blind, placebo controlled trial.
A) There is a chance you will be in the placebo group. The probability will depend on the trial and will range from a 50% to a 30% placebo group. Whichever group you are in, you will still benefit from the ongoing medical care and psychometric testing you will receive as part of the trial. At the end of the trial period, most trials offer the opportunity for you to enter the “open label extension”. This is when you continue in the trial on the active drug despite whichever group (placebo or active drug) you were in previously. The open label extension is un-blinded, so you will know you are on the active drug.
A) Any potential side effects will be listed in the patient information sheets sent to you prior to your initial consultation. Most side effects are non-specific, but some trials have specific side effects that your study doctor will discuss with you. If you have a primary care physician, we will work closely with him or her – and you – to ensure your safety at all times.
A) Absolutely. Leaving a study does not affect your medical or legal rights. And it is not necessary to give us a reason as to why you want to leave, although we always value any feedback. If you choose to leave after you have started taking the study drug, we are obligated to offer you a closing visit to carry out final medical investigations to ensure your safety.